protein

HEPSIN

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about HEPSIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

102Connections
9Hypotheses
0Analyses
50Outgoing
33Incoming
0Experiments
0Debates

Summary

Type II transmembrane serine protease with roles in APP processing, extracellular matrix remodeling, and potential implications in Alzheimer's disease and neurodegeneration.

View on Wiki →

No AI portrait yet

🔬 Protein Info
Gene SymbolHEPSIN
Chromosome19q13.12
Protein TypeProtease
Functionis a type II transmembrane serine protease (TTSP) that belongs to the family of trypsin-like serine proteases.
Primary Expressionvarious tissues, including the liver, kidney, and brain, where it plays important roles in extracellular matrix remodeling, cell growth, and signal tr
Amino Acids18 aa
GeneCardsHEPSIN
Human Protein AtlasHEPSIN
Associated Diseasesneurodegeneration
KG Connections102 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Hepsin Protein

protein · 1933 words

Pathway Diagram

graph TD
    HEPSIN("HEPSIN")
    IL_6("IL-6")
    HEPSIN -->|"co_discussed"| IL_6
    IL_8("IL-8")
    HEPSIN -->|"co_discussed"| IL_8
    IRISIN("IRISIN")
    HEPSIN -->|"co_discussed"| IRISIN
    SCRIB["SCRIB"]
    HEPSIN -->|"co_discussed"| SCRIB
    SPARC("SPARC")
    HEPSIN -->|"co_discussed"| SPARC
    STING["STING"]
    HEPSIN -->|"co_discussed"| STING
    ALZHEIMER["ALZHEIMER"]
    ALZHEIMER -->|"co_discussed"| HEPSIN
    BDNF["BDNF"]
    BDNF -->|"co_discussed"| HEPSIN
    FGF21["FGF21"]
    FGF21 -->|"co_discussed"| HEPSIN
    GENES["GENES"]
    GENES -->|"co_discussed"| HEPSIN
    neurodegeneration["neurodegeneration"]
    HEPSIN -->|"implicated_in"| neurodegeneration

Outgoing (69)

TargetRelationTypeStr
SCRIBco_discussedgene0.50
STINGco_discussedgene0.50
IL-6co_discussedprotein0.50
IL-8co_discussedprotein0.50
IRISINco_discussedprotein0.50

Incoming (33)

SourceRelationTypeStr
ALZHEIMERco_discussedgene0.50
GENESco_discussedgene0.50
BDNFco_discussedgene0.50
FGF21co_discussedgene0.50
AMPKco_discussedprotein0.40

Targeting Hypotheses (9)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Lysosomal Cathepsin-Dependent Tau Clearance 0.767 neurodegeneration Does the cancer-cystatin-C-TREM2 pathway
PD-Associated GWAS Variants in CTSO and CTSF Genes Create a 0.743 neurodegeneration -
Dual Calpain/Cathepsin B Inhibition as Primary Neuroprotecti 0.644 neurodegeneration Why does autophagy inhibition improve ne
Selective cathepsin B inhibition prevents cathepsin leakage- 0.620 neuroscience Lysosomal dysfunction and cathepsin leak
Limited Calcium Release Without Sufficient Cathepsin Efflux 0.580 neurodegeneration How does controlled lysosomal membrane p
Hsp70-based therapy to prevent lysosomal membrane permeabili 0.570 neuroscience Lysosomal dysfunction and cathepsin leak
Cathepsin D Replacement to Overcome Lysosomal Protease Defic 0.434 proteomics Quantitative proteomics of the aging syn
Cathepsin-Dependent Processing of Pro-Drug Enzymes 0.400 neurodegeneration How does controlled lysosomal membrane p
Cathepsin D Enhancement for Tau Degradation 0.000 - Tau propagation mechanisms and therapeut

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (7)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] Marogianni C, Sokratous M, Dardiotis E, International journal of molec 2020 0
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] Marogianni C, Sokratous M, Dardiotis E, International journal of molec 2020 0
Multiple Sclerosis Pathology. [PMID:29358320] Lassmann H Cold Spring Harbor perspective 2018 0
Tau, neurodegeneration and Alzheimer's disease. [PMID:21214513] Unknown Curr Alzheimer Res 2010 0
TNF-alpha signaling in glaucomatous neurodegeneration. [PMID:18929124] Unknown Prog Brain Res 2008 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning HEPSIN in their description or question text

Hsp70-based therapy to prevent lysosomal membrane permeabilization and cathepsin

Score: 0.570 · neuroscience · 2026-04-22

## Mechanistic Overview Hsp70-based therapy to prevent lysosomal membrane permeabilization and cathepsin release in AD s

Cathepsin D Replacement to Overcome Lysosomal Protease Deficiency

Score: 0.434 · proteomics · 2026-04-25

Cathepsin D Replacement to Overcome Lysosomal Protease Deficiency

Cathepsin-Dependent Processing of Pro-Drug Enzymes

Score: 0.400 · neurodegeneration · 2026-04-21

## Mechanistic Overview Cathepsin-Dependent Processing of Pro-Drug Enzymes starts from the claim that modulating CTSD, U

Cathepsin D Enhancement for Tau Degradation

Score: 0.000 · unknown disease · 2026-04-28

Recombinant pro-cathepsin D enhances pathological protein degradation in lysosomes. Targeted delivery of stabilized cath